Studies investigating neuroblastoma in transgenic TH-MYCN mouse models have shown that tumors undergo a transition from early lesions highly infiltrated with lymphocytes to progressively increasing numbers of myeloid populations in advanced tumors [7,8]. The gene discussed is MYCN; the disease is neuroblastoma.